Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

15.93
Delayed Data
As of Jun 29
 -0.26 / -1.61%
Today’s Change
12.56
Today|||52-Week Range
88.54
-73.98%
Year-to-Date
Endo Int'l (ENDP) Stock Up, BMO Initiates Coverage
Jun 29 / TheStreet.com - Paid Partner Content
Why Endo International plc Patented a Higher Stock Price
Jun 28 / MotleyFool.com - Paid Partner Content
Endo's Stock Gains on Vasostrict's New Patent Approval
Jun 29 / Zacks.com - Paid Partner Content
Endo International Jumps on Patent Approval, Still Has Work to Do
Jun 28 / TheStreet.com - Paid Partner Content
Endo International (ENDP) Showing Signs Of Perilous Reversal Today
Jun 29 / TheStreet.com - Paid Partner Content
Endo Int'l (ENDP) Stock Spikes on New FDA Patent
Jun 28 / TheStreet.com - Paid Partner Content
Why Southwestern Energy, Endo International, and LendingClub Jumped Today
Jun 28 / MotleyFool.com - Paid Partner Content
Today's Dead Cat Bounce Stock: Endo International (ENDP)
Jun 28 / TheStreet.com - Paid Partner Content
Endo International Shares Soar on Patent Approval
Jun 28 / TheStreet.com - Paid Partner Content
Endo's (ENDP) Pain Drug Opana ER to Face FDA Panel in Fall
Jun 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close16.19
Today’s open16.19
Day’s range15.20 - 16.37
Volume15,417,380
Average volume (3 months)9,521,884
Market cap$3.6B
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-0.53%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.72+2.27%
ICPTIntercept Pharmaceut...+0.50+0.33%
NBIXNeurocrine Bioscienc...+1.51+3.44%
AKRXAkorn Inc+0.61+2.18%
Data as of 06/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.80
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs